Long-term cholesterol-lowering effects of 4 fat-restricted diets in hypercholesterolemic and combined hyperlipidemic men: The dietary alternatives study

JAMA

Volumn 278, Issue 18, 1997, Pages 1509-1515

  Knopp, Robert H ^a,b   Walden, Carolyn E ^a,b   Retzlaff, Barbara M ^a,b   McCann, Barbara S ^a,c   Dowdy, Alice A ^a,b   Albers, John J ^b   Gey, George O ^d   Cooper, Manuel N ^d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Department of Medicine ^*  (United States)

^c Dept of Psychiat and Behav Sci   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; FAT INTAKE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030725867     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.278.18.1509     Document Type: Article

References (49)

1. Grundy SM, Denke MA. Dietary influences on serum lipids. J Lipid Res. 1990;31:1149-1172.
2. Chait A, Brunzell JD, Denke MA, et al. Rationale of the diet-heart statement of the American Heart Association: report of the Nutrition Committee. Circulation. 1993;88:3008-3029.
3. The Expert Panel. Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med. 1988;148:36-69.
4. The Expert Panel. Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993;269:3015-3023.
5. Bernard JR. Effects of life-style modification on serum lipids. Arch Intern Med. 1991;151:1389-1394.
6. Ornish D, Brown SE, Scherwitz LW, et al. Can lifestyle changes reverse coronary heart disease? the Lifestyle Heart Trial. Lancet. 1990;336:129-133.
7. Gotto AM, Bierman EL, Connor WE, et al. Recommendations for treatment of hyperlipidemia in adults. Circulation. 1984;72:1067A-1090A.
8. Grundy SM, Nix D, Whelan MF, Franklin L. Comparison of three cholesterol-lowering diets in normolipidemic men. JAMA. 1986;256:2351-2355.
9. Boyd NF, Cousin M, Beaton M, Kriukov V, Lock-wood G, Tritchler D. Quantitative changes in dietary fat intake and serum cholesterol in women: results from a randomized, controlled trial. Am J Clin Nutr. 1990;52:470-476.
10. Clevidence BA, Judd JT, Schatzkin A, et al. Plasma lipid concentrations of men consuming a low-fat, high-fiber diet. Am J Clin Nutr. 1992;55:689-694.
11. Brown GD, Whyte L, Gee MI, et al. Effects of two 'lipid lowering' diets on plasma lipid levels of patients with peripheral vascular disease. J Am Diet Assoc. 1984;84:546-550.
12. Kasim SE, Martino S, Kim P-N, et al. Dietary and anthropometric determinants of plasma lipo-proteins during a long-term low-fat diet in healthy women. Am J Clin Nutr. 1993;57:146-153.
13. Thuesen L, Henriksen LB, Engby B. One-year experience with a low-fat, low-cholesterol diet in patients with coronary heart disease. Am J Clin Nutr. 1986;44:212-219.
14. Schaefer EJ, Lichtenstein AH, Lamon-Fava S, et al. Body weight and low-density lipoprotein cholesterol changes after consumption of a low-fat ad libitum diet. JAMA. 1995;274:1450-1455.
15. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG. Hyperlipidemia in coronary heart disease, II: genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest. 1973; 52:1544-1568.
16. Manninen V, Elo O, Frick H, et al. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA. 1988; 260:641-651.
17. Austin MA. Plasma triglyceride and coronary heart disease. Arteriosclerosis. 1991;11:2-14.
18. Havel RJ, Kane JP. Introduction: structure and metabolism of plasma lipoproteins. In: Scrives CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. New York, NY: McGraw-Hill; 1989:1129-1138.
19. Walden CE, McCann BS, Retzlaff B, et al. Alternative fat-restricted diets for hypercholesterolemia and combined hyperlipidemia: feasibility, design, subject recruitment, and baseline characteristics of the Dietary Alternatives Study. J Am Coll Nutr. 1991;10:429-442.
20. The Lipid Research Clinics. Population Studies Data Book, I: The Prevalence Study. Washington, DC: US Dept of Health and Human Services, Public Health Service; 1980:1-136. National Institutes of Health publication 80-1527.
21. American Heart Association. Counseling the Patient With Hyperlipidemia. Dallas, Tex: American Heart Association National Center; 1984.
22. American Diabetes Association and American Dietetic Association. Exchange Lists for Meal Planning. Alexandria, Va, and Chicago, Ill: American Diabetes Association and American Dietetic Association; 1986.
23. McCann BS, Retzlaff BM, Dowdy MS, Walden CE, Knopp RH. Promoting adherence to low-fat, low cholesterol diets: review and recommendations. J Am Diet Assoc. 1990;90:1408-1414.
24. Dennis B, Ernst H, Hjortland M, Tillotson J, Grambsch V. The NHLBI nutrition data system. J Am Diet Assoc. 1980;77:641-647.
25. Lipid Research Clinics. Manual of Laboratory Operations: Lipid Research Clinics Program, Volume I. Bethesda, Md: National Institutes of Health; 1974. DHEW publication NIH 75-628.
26. Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2+ precipitation procedure for quantification of high-density lipoprotein cholesterol. Clin Chem. 1982;28:1379-1388.
27. Warnick GR. Enzymatic methods for quantification of lipoprotein lipids. Methods Enzymol.1986; 129:101-123.
28. Albers JJ, Cabana VG, Hazzard WR. Immunoassay of human plasma apolipoprotein B. Metabolism. 1975;24:1339-1351.
29. Adolphson JL, Albers JJ. Comparison of two commercial nephelometric methods for apoprotein A-I and apoprotein B with standardized apoprotein A-I and B radioimmunoassays. J Lipid Res. 1989; 30:597-606.
30. Roman AT. Automated glucose methods: evaluation of a glucose oxidase-peroxidase procedure. Clin Chem. 1973;19:1152-1157.
31. Morgan CR, Lazarow A. Immunoassay of insulin to antibody system. Diabetes. 1963;21:115-126.
32. Childs MT, King IB, Knopp RH. Effect of fish oils with varying eicosapentanoic to docosahexanoic acid ratios on plasma lipids in normal subjects. Am J Clin Nutr. 1990;52:632-640.
33. Kleinbaurn DG, Kupper LL. Applied regression analysis and other multivariable methods. North Scituate, Mass: Duxbury Press; 1978:244-288.
34. Toothaker LE. Multiple comparisons for researchers. Newbury Park, Calif: Sage Publications; 1991:50-52.
35. Glatz JF, Soffers AE, Katan MB. Fatty acid composition of serum cholesterol esters and erythrocyte membranes as indicators of linoleic acid intake in man. Am J Clin Nutr. 1989;49:269-276.
36. Schaefer EJ, Lichtenstein AH, Lamon-Fava S, et al. Effects of National Cholesterol Education Program Step 2 diets relatively high or relatively low in fish-derived fatty acids on plasma lipoproteins in middle-aged and elderly subjects. Am J Clin Nutr. 1996;63:234-241.
37. Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr. 1992;56:320-328.
38. Lichtenstein AH, Ausman LM, Carrasco W, Jenner JL, Ordovas JM, Schaefer EJ. Short-term consumption of a low-fat diet beneficially affects plasma lipid concentrations only when accompanied by weight loss: hypercholesterolemia, low-fat diet, and plasma lipids. Arterioscler Thromb. 1994;14: 1751-1760.
39. Katzel LI, Coon PJ, Dengel J, Goldberg AP. Effects of an American Heart Association Step I diet and weight loss on lipoprotein lipid levels in obese men with silent myocardial ischemia and reduced high-density lipoprotein cholesterol. Metabolism. 1995;44:307-314.
40. Assman G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Am J Cardiol. 1992;70: 733-737.
41. Vessby B, Lithell H. Dietary effects on lipoprotein levels in hyperlipoproteinemia: delineation of two subgroups of endogenous hypertriglyceridemia. Artery. 1974;1:63-68.
42. Cominacini L, Zocca I, Garbin U, et al. Long-term effect of a low-fat, high-carbohydrate diet on plasma lipids of patients affected by familial endogenous hypertriglyceridemia. Am J Clin Nutr. 1988; 48:57-65.
43. Lavie CJ, Milani RV. Effects of cardiac rehabilitation and exercise training on low-density lipoprotein cholesterol in patients with hypertriglyceridemia and coronary artery disease. Am J Cardiol. 1994;74:1192-1195.
44. Rapp JH, Lespine A, Hamilton RL, et al. Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunoabsorption from human atherosclerotic plaque. Arterioscler Thromb. 1994;14:1767-1774.
45. Brown BG, Albers JJ, Fisher LD, et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apoprotein B. N Engl J Med. 1990;323:1289-1298.
46. Retzlaff BM, Walden CW, Dowdy AA, McCann BS, Anderson KA, Knopp RH. Changes in plasma triacylglycerol concentrations among free-living hyperlipidemic men adopting different carbohydrate intakes over 2 y: the Dietary Alternatives Study. Am J Clin Nutr. 1995;62:988-995.
47. Bovbjerg VE, McCann BS, Knopp RH. Cholesterol lowering by dietary means is not associated with increased depression or hostility. Ann Behav Med. 1994;16(suppl):49. Abstract.
48. Retzlaff BM, Dowdy AA, Walden CE, et al. Changes in vitamin and mineral intakes and serum levels among free-living men on cholesterol-lowering diets: the Dietary Alternatives Study. Am J Clin Nutr. 1991;53:890-898.
49. Retzlaff BM, Walden CW, McNeney WB, Dowdy AA, Knopp RH. Zinc intake and plasma zinc level are maintained in men consuming cholesterol-lowering diets. J Am Diet Assoc. 1995;95:1274-1279.